The Dapagliflozin And Prevention of Adverse outcomes in Heart Failure trial (DAPA-HF) in context. McMurray JJV, Solomon SD, Docherty KF, Jhund PS, et al. Eur Heart J 2020 Jan 3. pii: 5695523. doi: 10.1093.

Read + Share

Amedeo Smart

Independent Medical Education

McMurray JJV, Solomon SD, Docherty KF, Jhund PS, et al. The Dapagliflozin And Prevention of Adverse outcomes in Heart Failure trial (DAPA-HF) in context. Eur Heart J 2020 Jan 3. pii: 5695523. doi: 10.1093.
PMID: 31898736